|
Recognition and Publications
- Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288(19):2421-31, 2002.
- Appel LJ, Middleton, J, Miller ER, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas LD, Charleston J, Gasssman, J, Greene, T, Jamerson, K, Kusek JW, Lewis JA, Phillips RA, Rostand, SG , Wright JT for the AASK Collaborative Research Group The Rationale and Design of the AASK Cohort Study. JASN 14(7 Suppl 2):S166-72. 2003.
- Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Rostand SG, Miller E, Smith W, Bakris GL. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med. 2005;165(8):947-53.
- Herman ES, Rafey MA, Akalin E, Winston JA, Murphy B. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation. 2005 Jun 27;79(12):1768-9; 5.
- Keith C. Norris, Tom Greene, Joel Kopple, Janice Lea, Julia Lewis, Mike Lipkowitz, Peter Miller, Annie Richardson, Stephen Rostand, Xuelie Wang, Lawrence G. Appel for the AASK Study Group. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. JASN 17(10), 2006.
|
|
|
